Valeant Prices Upsized $1.5B Bond To Refinance Debt
Valeant Pharmaceuticals Inc. on Monday priced an upsized $1.5 billion private bond offering that will refinance previously issued debt, marking the Canadian drug giant's third major bond sale this year as...To view the full article, register now.
Already a subscriber? Click here to view full article